Skip to main content
. 2023 Aug 19;21(8):457. doi: 10.3390/md21080457

Table 3.

The IC90 values (μM) of antibacterial bioassays of compounds 110 a.

1 2 3 4 5 6 7 8 9 10 TC OT LF
Streptococcus parauberis FP KSP28 0.3 0.5 2.7 0.1 4.9 1.1 0.5 8.9 4.4 1.0 6.3 3.1 3.1
Phoyobacterium damselae FP2244 9.1 4.2 11.0 8.5 9.8 9.2 2.2 2.2 4.4 2.0 0.1 0.1 0.1
Streptococcus parauberis SPOF3K 9.1 4.2 11.0 8.5 9.8 4.6 2.2 2.2 4.4 2.0 >50.0 25.0 3.1
Aeromonas salmonicida AS42 - b - - - - - 8.8 - - - 12.7 0.8 0.8
Enterococcus faecium G1 - - - - - - 8.8 - - 8.0 0.2 0.4 >100.0
Enterococcus faecium G4 - - - - - - - - - 4.0 0.4 0.4 >100.0
Enterococcus faecium G7 - 16.8 - - - 18.3 8.8 8.9 4.4 8.0 0.2 0.2 >100.0
Enterococcus faecium G8 - - - - - - - - - 8.0 0.2 0.1 >100.0
Streptococcus agalactiae WR10 18.1 8.4 22.0 17.0 - - 4.4 4.4 - 4.0 1.6 1.6 6.3

a Tetracycline hydrochloride (TC), oxytetracycline hydrochloride (OT), levofloxacin hydrochloride (LF) were used as positive controls. b ‘-’ indicated they were not subjected to the antibacterial rescreening experiments since their inhibition rates against these bacteria were <90% in the preliminary antibacterial bioassays.